Biopharmaceutics Risk Assessment to Guide Dissolution Method Development for Solid Oral Dosage Forms

  Рет қаралды 3,747

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Пікірлер
Decrease RTR, IR, and CR Due to Dissolution Deficiencies (21of28) GDF - Apr. 3-4, 2019
35:21
U.S. Food and Drug Administration
Рет қаралды 1,8 М.
Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA
1:56:59
U.S. Food and Drug Administration
Рет қаралды 10 М.
Quando A Diferença De Altura É Muito Grande 😲😂
00:12
Mari Maria
Рет қаралды 45 МЛН
Quando eu quero Sushi (sem desperdiçar) 🍣
00:26
Los Wagners
Рет қаралды 15 МЛН
We Attempted The Impossible 😱
00:54
Topper Guild
Рет қаралды 56 МЛН
Chemistry and Manufacturing Requirements for Early Clinical Development: What’s in there? Prove it.
1:02:19
Dissolution Method Development for Generic Drugs (24/28) Generic Drugs Forum 2017
15:23
U.S. Food and Drug Administration
Рет қаралды 6 М.
Navigating First ICH Generic Drug Draft Guideline M13A Bioequivalence for IR Solid Oral Dosage Forms
2:25:28
Biopharmaceutics Classification System Class 3 Waiver
19:19
U.S. Food and Drug Administration
Рет қаралды 2,7 М.
An In-Depth Look at the Final FDA Guidance: Bioavailability Studies Submitted in NDAs or INDs
2:35:24
Bioequivalence Regulations and Product-Specific Guidances
19:15
U.S. Food and Drug Administration
Рет қаралды 3,1 М.
Manufacturing Process and Controls (25/28) Generic Drugs Forum 2017
16:23
U.S. Food and Drug Administration
Рет қаралды 2,6 М.
Panel Discussion
24:45
U.S. Food and Drug Administration
Рет қаралды 330
Bench to Bedside Chat Pharmacology and Dose Optimization for First-in-Human Oncology Trials
1:27:06
U.S. Food and Drug Administration
Рет қаралды 1,9 М.
FDA Clinical Investigator Training Course (CITC) 2024 - Day One - Session One
2:14:51
U.S. Food and Drug Administration
Рет қаралды 524
Quando A Diferença De Altura É Muito Grande 😲😂
00:12
Mari Maria
Рет қаралды 45 МЛН